Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Debate exists as to whether the higher hemoglobin A1c (HbA1c) levels observed in black persons than in white persons are due to worse glycemic control or racial differences in the glycation of hemoglobin. Objective To determine whether a racial difference exists in the relationship of mean glucose and HbA1c. Design Prospective, 12-week observational study. Setting 10 diabetes centers in the United States. Participants 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 years and had an HbA1c level of 6.0% to 12.0%. Measurements Mean glucose concentration, measured by using continuous glucose monitoring and compared by race with HbA1c, glycated albumin, and fructosamine values. Results The mean HbA1c level was 9.1% in black persons and 8.3% in white persons. For a given HbA1c level, the mean glucose concentration was significantly lower in black persons than in white persons (P = 0.013), which was reflected in mean HbA1c values in black persons being 0.4 percentage points (95% CI, 0.2 to 0.6 percentage points) higher than those in white persons for a given mean glucose concentration. In contrast, no significant racial differences were found in the relationship of glycated albumin and fructosamine levels with the mean glucose concentration (P > 0.20 for both comparisons). Limitation There were too few participants with HbA1c levels less than 6.5% to generalize the results to such individuals. Conclusion On average,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A1C levels may be 0.4% to 0.6% higher in Blacks and Hispanics compared with Whites, despite equivalent levels of hyperglycemia in those with T2D.11-17”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [17]
In the citing paper
“At the same average glucose values, HbA 1c was approximately 0.4% higher in the former compared with the latter.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“A study in type 1 diabetes demonstrated a difference in the relationship between mean average glucose measured with CGM and HbA 1c in Black compared with White participants (342).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“As discussed in section 2, “Diagnosis and Classification of Diabetes,” there is controversy regarding the clinical significance of differences in A1C by self-reported race and ethnicity (9)(10)(11)(12).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [9]
In the citing paper
“Studies have found that African American individuals have slightly higher A1C levels than non-Hispanic White or Hispanic people (22 -25).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citationContinuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737 · cited 1×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 2×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundMethodHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Self-citationA1c versus glucose testing: a comparison
Sacks, D. B. (2011) · Diabetes Care · doi:10.2337/dc10-1546 · Cited by 461 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundGlycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study
Petitti, D. B., Klingensmith, G. J., Bell, R. A., Andrews, J. S., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., Standiford, D., Waitzfelder, B., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.025 · Cited by 397
Self-citationTahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380 · cited 3×
“Similar analyses to those described above were conducted for fructosamine and glycated albumin, using a maximum of 42 and 53 days of prior CGM data, respectively (28).”
MethodInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-citation
Research works printed but not linked: 1
- Boltri JM, 2005, Ethn Dis, 15, 562
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Self-citation2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Self-citationInternational consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citationState of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
“genetic differences in red blood cell life span, differences in red blood cell glycation rates, or other, as of yet undefined, biologic or genetic factors.(14) Of interest, a difference in HbA1c levels between race/ethnicities exists even among those in the highest income category.”
BackgroundSelf-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 762
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
“in African Americans than in whites at a given mean glucose concentration (8,9).”
BackgroundHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“Variability within races is greater than variability between races (293).”
Self-citation6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s006 · Cited by 655
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
Self-citationDiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
Self-citationLu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1131 · Cited by 517
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
Self-citationThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
“was illustrated in a recent study we and others conducted assessing racial differences in the mean glucose–HbA1c relationship (4).”
Self-citation2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
The relationship of hemoglobin A1C to time-in-range in patients with diabetes
Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464
“Since the relationship of HbA1c to mean blood glucose differs by race and/or ethnicity, 29 the regression equation may not be accurate for those who are not Caucasian.”
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citation6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Self-citationQaseem, A., Wilt, T. J., Kansagara, D., Horwitch, C., Barry, M. J., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2018) · Annals of Internal Medicine · doi:10.7326/m17-0939 · Cited by 412
Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016
Andes, L. J., Cheng, Y. J., Rolka, D. B., Gregg, E. W., & Imperatore, G. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.4498 · Cited by 380
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
Riddlesworth, T. D., Beck, R. W., Gal, R. L., Connor, C. G., Bergenstal, R. M., Lee, S., & Willi, S. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0455 · Cited by 266
“The following CGM metrics were analyzed: (1) mean sensor glucose concentration, (2) percentage of time in the target range of 70–180 mg/dL, (3) percentage of time in the hyperglycemic range (>180 and >250 mg/dL), (4) percentage of time in the hypoglycemic range (<70 and <54 mg/dL), and (5) coefficient of variation (CV…”
MethodSelf-citationISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth
Zeitler, P., Arslanian, S., Fu, J., Pinhas-Hamiel, O., Reinehr, T., Tandon, N., Urakami, T., Wong, J., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12719 · Cited by 221
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring
Edelman, S. V., Argento, N. B., Pettus, J., & Hirsch, I. B. (2018) · Diabetes Care · doi:10.2337/dc18-1150 · Cited by 199
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes
Agarwal, S., Kanapka, L. G., Raymond, J. K., Walker, A., Gerard-Gonzalez, A., Kruger, D., Redondo, M. J., Rickels, M. R., Shah, V. N., Butler, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa236 · Cited by 205
Self-citationPettus, J. H., Zhou, F. L., Shepherd, L., Preblick, R., Hunt, P. R., Paranjape, S., Miller, K. M., & Edelman, S. V. (2019) · Diabetes Care · doi:10.2337/dc19-0830 · Cited by 160
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Positioning time in range in diabetes management
Advani, A. (2020) · Diabetologia · doi:10.1007/s00125-019-05027-0 · Cited by 170
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Miller, K. M., Beck, R. W., Foster, N. C., Maahs, D. M., & Exchange, F. T. T. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0393 · Cited by 162
Self-citationLittle, R. R., Rohlfing, C., & Sacks, D. B. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.296962 · Cited by 161
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 133
Self-citationMajidi, S., Ebekozien, O., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K., Izquierdo, R., Demeterco-Berggren, C., Polsky, S., Basina, M., et al. (2021) · Clinical Diabetes · doi:10.2337/cd21-0028 · Cited by 118
Peralta, F. G., Choudhary, P., Cosson, E., Irace, C., Rami-Merhar, B. M., & Seibold, A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14638 · Cited by 121
“The haemoglobin glycation index (HGI) has been proposed to explain biological variation in HbA1c predictions for risk of retinopathy and nephropathy (Figure 2).(10,11) HGI is the difference between”
BackgroundCardiovascular and Kidney Outcomes Across the Glycemic Spectrum
Honigberg, M. C., Zekavat, S. M., Pirruccello, J. P., Natarajan, P., & Vaduganathan, M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.004 · Cited by 108
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors
Redondo, M. J., Libman, I., Cheng, P., Kollman, C., Tosur, M., Gal, R. L., Bacha, F., Klingensmith, G. J., Clements, M., Pediatric Diabetes Consortium, et al. (2018) · Diabetes Care · doi:10.2337/dc17-2335 · Cited by 103
“A recent study demonstrated that, although part of the HbA1c difference between NHW and AA individuals may be related to HbA1c overestimation of mean glucose concentration in AAs compared with NHWs, not all the differencewas attributable to this effect (29).”
BackgroundSelf-citationKahkoska, A. R., Shay, C. M., Crandell, J., Dabelea, D., Imperatore, G., Lawrence, J. M., Liese, A. D., Pihoker, C., Reboussin, B. A., Agarwal, S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1851 · Cited by 97
Racial disparities in treatment and outcomes of children with type 1 diabetes
Lipman, T. H., Smith, J. A., Patil, O., Willi, S. M., & Hawkes, C. P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13139 · Cited by 103
Self-citationHbA1c and Glucose Management Indicator Discordance: A Real-World Analysis
Perlman, J. E., Gooley, T. A., McNulty, B., Meyers, J., & Hirsch, I. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0501 · Cited by 93
“Previous research suggests that HbA1c is higher in African Americans for any given mean glucose (larger discordance).(12) Our patients were predominantly Caucasian (1% African American) thus negating this potential biological explanation.”
BackgroundHbA1c: a review of non-glycaemic variables
Campbell, L., Pepper, T., & Shipman, K. E. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204755 · Cited by 105
“4% than whites for comparable average glucose measures.(46) While these differences are not of definitive clinical significance, the results do suggest further work should be undertaken to better understand the impact of ethnicity on HbA1c.”
BackgroundPotential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap
Nayak, A., Singh, B. M., & Dunmore, S. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00284 · Cited by 103
The trials and tribulations of determining HbA1c targets for diabetes mellitus
Klein, K. R., & Buse, J. B. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00425-6 · Cited by 97
Ferreira, R. O. M., Trevisan, T., Pasqualotto, E., Chavez, M. P., Marques, B. F., Lamounier, R. N., & van de Sande-Lee, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0390 · Cited by 92
REDONDO, M. J., Libman, I. M., Maahs, D. M., Lyons, S. K., Saraco, M., Reusch, J. E. B., Rodriguez, H., & DiMeglio, L. A. (2021) · Diabetes Care · doi:10.2337/dc20-1978 · Cited by 95
Self-citationBergenstal, R. M., Mullen, D. M., Strock, E., Johnson, M. L., & Xi, M. X. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108106 · Cited by 87
Self-citationRunge, A. S., Kennedy, L., Brown, A. S., Dove, A. E., Levine, B. J., Koontz, S. P., Iyengar, V. S., Odeh, S. A., Close, K. L., Hirsch, I. B., et al. (2018) · Clinical Diabetes · doi:10.2337/cd17-0094 · Cited by 87
“A recent study demonstrated a range of ~80 mg/dL in average glucose for the same A1C level (15).”
BackgroundAdherence to the Mediterranean diet by the Greek and Cypriot population: a systematic review
Kyriacou, A., Evans, J. M. M., Economides, N., & Kyriacou, A. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv124 · Cited by 100
Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus
Klonoff, D. C. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819841698 · Cited by 77
“Blacks and populations of Middle-East ancestry, compared to nHws have been shown on average to have higher HbA1c values, even after adjustment for factors likely to affect glycemia, although there are much wider differences within races than between races.(9,27,28) In a study of 3189 individuals with impaired glucose…”
BackgroundEffects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial
Dorans, K. S., Bazzano, L. A., Qi, L., He, H., Chen, J., Appel, L. J., Chen, C.-S., Hsieh, M.-H., Hu, F. B., Mills, K. T., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.38645 · Cited by 58
Berard, L. D., Siemens, R., & Woo, V. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.007 · Cited by 69
Reddy, N., Verma, N., & Dungan, K. M. (2020) · MDText.com, Inc. eBooks · Cited by 108
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., & Zhou, T. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11643 · Cited by 62
Sarnowski, C., Leong, A., Raffield, L. M., Wu, P., de Vries, P. S., DICORPO, D. A., Guo, X., Xu, H., Liu, Y., Zheng, X., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.08.010 · Cited by 60
Fabris, C., Heinemann, L., Beck, R., Cobelli, C., & Kovatchev, B. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0236 · Cited by 58
“4% higher than those of non-Hispanic white persons for a given continuous glucose monitoring (CGM)-derived mean glucose concentration.(15) Since a wide range of mean glucose concentrations can be associated with the same HbA1c level, reflecting at least in part differences in individual glycation rates, the use of HbA…”
BackgroundSelf-citationDemeterco‐Berggren, C., Ebekozien, O. A., Noor, N., Rompicherla, S., Majidi, S., Jones, N. Y., McDonough, R., Odugbesan, O., Kim, A., Izquierdo, R. E., et al. (2022) · Clinical Diabetes · doi:10.2337/cd22-0073 · Cited by 62
“reported, it has been shown that these account for a small fraction of the differences found between these racial/ethnic groups (23).”
BackgroundTundidor, D., Meek, C. L., Yamamoto, J. M., Martínez-Brú, C., Gich, I. J., Feig, D. S., Murphy, H. R., Corcoy, R., On Behalf of the CONCEPTT Collaborative Group, Murphy, H. R., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0073 · Cited by 63
Çöpür, S., Onal, E. M., Afşar, B., Ortíz, A., van Raalte, D. H., Cherney, D. Z. I., Rossing, P. R., & Kanbay, M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107707 · Cited by 61
Zelnick, L. R., Batacchi, Z. O., Ahmad, I., Dighe, A., Little, R. R., Trence, D. L., Hirsch, I. B., & de Boer, I. H. (2020) · Diabetes Care · doi:10.2337/dc20-0915 · Cited by 55
Smalls, B. L., Ritchwood, T. D., Bishu, K. G., & Egede, L. E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030950 · Cited by 54
“Moreover, these findings also raise questions about the validity of using HbA1c alone to screen individuals for T2DM [25], as there is evidence that HbA1c levels overestimate blood glucose concentration among ethnic minorities [24] and that non-Hispanic Blacks may differ in their glycation of hemoglobin [24].”
BackgroundISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets
de Bock, M., Agwu, J. C., Deabreu, M., Dovc, K., Maahs, D. M., Marcovecchio, M. L., Mahmud, F. H., Nóvoa-Medina, Y., Priyambada, L., Smart, C. E., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543266 · Cited by 52
“…HbA1c, there is a wide range of mean glucose concentration values, and for any given mean glucose value there is a wide range of HbA1c values [65], (ii) racial differences [66], and (iii) unreliable measurement in certain conditions including anemia, hemo-globinopathies, and liver disease [58].”
Self-citationGalderisi, A., Giannini, C., Weiss, R., Kim, G. E., Shabanova, V., Santoro, N., Pierpont, B. M., Savoye, M., & Caprio, S. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30235-9 · Cited by 54
“4% higher HbA1c than NHW for a given mean glucose concentration, (38) as confirmed by the baseline HbA1c of our cohort.”
BackgroundTime-in-range for monitoring glucose control: Is it time for a change?
Bellido, V., Pinés-Corrales, P. J., Villar‐Taibo, R., & Ampudia‐Blasco, F. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108917 · Cited by 52
Menke, A., Casagrande, S., & Cowie, C. C. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.07.012 · Cited by 45
Gonzalez, A., Deng, Y., Lane, A. N., Benkeser, D. C., Cui, X., Staimez, L. R., Ford, C. N., Khan, F. N., WEBSTER, S. C. M., Leong, A., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14181 · Cited by 49
Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes
Hsia, D. S., Rasouli, N., Pittas, A. G., Lary, C. W., Peters, A. L., Lewis, M. R., Kashyap, S. R., Johnson, K., LeBlanc, E. S., Phillips, L. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa029 · Cited by 46
Assessment of glycemia in chronic kidney disease
Hassanein, M., & Shafi, T. (2022) · BMC Medicine · doi:10.1186/s12916-022-02316-1 · Cited by 48
“87), supporting their role as alternative glycemic markers [31].”
BackgroundYang, G., Yeung, S. L. A., & Schooling, C. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104259 · Cited by 48
Wang, S., Ji, X., Zhang, Z., & Xue, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155317 · Cited by 56
“HbA1c was used as an indicator of glycemic control in most previous studies [13,14].”
MethodDunn, T. C., Xu, Y., Bergenstal, R. M., Ogawa, W., & Ajjan, R. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0146 · Cited by 47
“26–28 HbA1c has been shown to reflect different glucose levels in different groups of people, 29–31 and there has been concern raised for how this can have a particularly large effect on those with African decent 32,33 and those of older age.”
Self-citationKhosla, L., Bhat, S., Fullington, L. A., & Horlyck-Romanovsky, M. F. (2021) · Preventing Chronic Disease · doi:10.5888/pcd18.200365 · Cited by 40
“African American people may have higher HbA1c values across the glycemic spectrum (9,13), and African immigrants may have lower HbA1c values compared with White people (14).”
PAULEY, M. E., Tommerdahl, K. L., Snell‐Bergeon, J. K., & Forlenza, G. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01799-x · Cited by 46
Kovatchev, B. P., Lobo, B. J., Fabris, C., Ganji, M., Fathi, A. E., Breton, M. D., Kanapka, L. G., Kollman, C., Battelino, T., & Beck, R. W. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0404 · Cited by 37
Self-citationCohen, R. M., Franco, R. S., Smith, E. P., & Higgins, J. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02409 · Cited by 36
Results of a Study Comparing Glycated Albumin to Other Glycemic Indices
Desouza, C. V., Holcomb, R. G., Rosenstock, J., Frías, J. P., Hsia, S. H., KLEIN, E. J., Zhou, R., Kohzuma, T., & Fonseca, V. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz087 · Cited by 37
Lee, S., Lacy, M. E., Jankowich, M., Correa, A., & Wu, W.-C. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100210 · Cited by 33
“This may be especially important given the consistent higher HbA1c for comparable average blood glucose values seen in AA populations in general compared to whites [29].”
BackgroundSelf-citationZang, L., Li, Y., Hao, H., Liu, J., Zhang, Q., Gao, F., Wang, H., Chen, Y., Gu, W., Du, J., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad060 · Cited by 37
“20,21 Furthermore, HbA1c provides only an average glucose level over the previous 2-3 months and does not reflect individual distinct glucose profiles.”
BackgroundCalliari, L. E., Krakauer, M., Vianna, A. G. D., Ram, Y., Barbieri, D. E., Xu, Y., & Dunn, T. C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0513-z · Cited by 40
“Moreover, a range of mean glucose values and glucose profiles can be associated with a single A1c measure [3].”
BackgroundBabaya, N., Noso, S., Hiromine, Y., Taketomo, Y., Niwano, F., Yoshida, S., Yasutake, S., Kawabata, Y., & Ikegami, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-83599-x · Cited by 38
Ethnic Disparities in Diabetes
Mikhail, N. E., Wali, S., & Brown, A. F. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.006 · Cited by 34
Protein glycation in diabetes mellitus
Shin, A., Connolly, S. M., & Kabytaev, K. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.003 · Cited by 38
Østergaard, H. B., Mandrup-Poulsen, T. R., Berkelmans, G. F. N., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.006 · Cited by 33
da Rosa, L. C. G. F., Zajdenverg, L., Souto, D. L., Dantas, J. R., Pinto, M. V., de Salles, G. F. D. C. M., & Rodacki, M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.022 · Cited by 34
Xu, Y., Dunn, T. C., & Ajjan, R. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819897613 · Cited by 32
“Numbers 54 66 120 Sex (M/F) 37/17 42/24 79/41 Age (year) 42 (33-51) 61 (54-66) 52 (44-62) Diabetes duration (years) 20 (13-27) 18 (11-23) 19 (13-24) Screening HbA1c (%) 6.”
Scheinker, D., Gu, A., Grossman, J., Ward, A., Ayerdi, O., Miller, D., Leverenz, J. C., Hood, K. K., Lee, M. Y., Maahs, D. M., et al. (2022) · JMIR Diabetes · doi:10.2196/27284 · Cited by 34
Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
Subramanian, S., & Hirsch, I. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0979-3 · Cited by 35
Nwosu, B. U. (2019) · European Medical Journal · doi:10.33590/emj/10310168 · Cited by 34
Bhat‐Nakshatri, P., Gao, H., Khatpe, A. S., Adebayo, A. K., McGuire, P. C., Erdoğan, C., Chen, D., Jiang, G., New, F., German, R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03011-9 · Cited by 32
“…variability in the utility of disease biomarkers, mutation patterns in cancer, response to treatment and outcomes, there has been an increased recognition of the importance of including tissues from people of different genetic ancestry to make research representative of all people 8,32–35 .”
Riddle, M. C., Gerstein, H. C., & Cefalu, W. T. (2017) · Diabetes Care · doi:10.2337/dci17-0049 · Cited by 30
Kazemi, M., Kim, J. Y., Wan, C., Xiong, J. D., Parry, S. A., Azziz, R., & Lujan, M. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.07.032 · Cited by 30
Maxwell, A., Jones, N. Y., Taylor, S. C., Corathers, S. D., Rasnick, E., Brokamp, C., Riley, C. L., Parsons, A. A., Kichler, J., & Beck, A. F. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3664 · Cited by 30
“Census tract poverty 11 (5-23) 8 (4-19) 15% (7-31) < .”
Past, Present, and Future of Continuous Glucose Monitors
Garg, S. K. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0041 · Cited by 31
Metadata
- Authors
- Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., Rickels, M., DiMeglio, L. A., Bethin, K. E., Marcovina, S., Tassopoulos, A., Lee, S., Massaro, E., Bzdick, S., Ichihara, B., Markmann, E., McGuigan, P., Woerner, S., Ecker, M., Beck, R. W., & for the T1D Exchange Racial Differences Study Group*
- Affiliations
- Children's Hospital of Philadelphia (US)
- From International Diabetes Center Park Nicollet, Minneapolis, Minnesota; Jaeb Center for Health Research, Tampa, Florida; University Hospitals of Cleveland, Cleveland, Ohio; Henry Ford Health System, Detroit, Michigan; Children's Hospital of Philadelphia and Perelman School of Medicine and Rodebaugh Diabetes Center, University of Pennsylvania, Philadelphia, Pennsylvania; Northwestern University, Chicago, Illinois; SUNY Upstate Medical University, Syracuse, New York;
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-07-18
- Volume
- 167
- Issue
- 2
- Pages
- 95-102
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2625092562
- Semantic Scholar
- f0f7e81895f364d37c2c4682799f26717d554b9e
- Cited by
- 306
- References
- 40
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 32 · 2023: 29 · 2022: 39 · 2021: 40 · 2020: 41 · 2019: 31 · 2018: 37 · 2017: 11
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HbA1c, racial differences, type 1 diabetes, glycemic control, hemoglobin glycation, glycated albumin, fructosamine, Black patients, continuous glucose monitoring
- MeSH terms
- Glycated Serum Albumin, Adolescent, Adult, Black or African American, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Prospective Studies, Serum Albumin, United States, Blood Glucose Self-Monitoring, Glycation End Products, Advanced, Fructosamine, Black People, White People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.